id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-N-0231-0002,FDA,FDA-2001-N-0231,Medical Devices; Reclassification of the Cutaneous Carbon Dioxide and the Cutaneous Oxygen Monitor,Notice,Notice of Final Rule,2002-12-17T05:00:00Z,2002,12,,,2025-02-10T16:31:24Z,02-31442,0,0,09000064804e5f44
FDA-2001-N-0231-0001,FDA,FDA-2001-N-0231,Medical Devices; Reclassification of the Cutaneous Carbon Dioxide (PcCO 2) and the Cutaneous Oxygen (PcO 2) Monitor,Notice,NPR-Notice of Proposed Rule-Making,2002-02-13T05:00:00Z,2002,2,2002-02-12T05:00:00Z,2002-04-16T03:59:59Z,2025-02-10T16:19:00Z,02-3281,0,0,09000064804e5eed